Related content

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

By Kolitz Jonathan E.   George Stephen L.   Benson Don M.   Maharry Kati   Marcucci Guido   Vij Ravi   Powell Bayard L.   Allen Steven L.   DeAngelo Daniel J.   Shea Thomas C.   Stock Wendy   Bakan Courtney E.   Hars Vera   Hoke Eva   Bloomfield Clara D.   Caligiuri Michael A.   Larson Richard A.    

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1010-1017

Blackwell Publishing

Access to resources Recommend Favorite

Health care utilization and end-of-life care for older patients with acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2840-2848

Blackwell Publishing

Access to resources Recommend Favorite

RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients

By Cao Xueyuan   Mitra Amit K   Pounds Stanley   Crews Kristine R   Gandhi Varsha   Plunkett William   Dolan M Eileen   Hartford Christine   Raimondi Susana   Campana Dario   Downing James   Rubnitz Jeffrey E   Ribeiro Raul C   Lamba Jatinder K  

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1449-1466

Future Medicine

Access to resources Recommend Favorite

Daunorubicin Metabolism in Leukemic Cells Isolated from Patients with Acute Myeloid Leukemia

By  

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 228-232

Bentham Science Publishers

Access to resources Recommend Favorite

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 6-19

Bentham Science Publishers

Access to resources Recommend Favorite